ClinicalTrials.Veeva

Menu

Handling Medium for ICSI With Ionomycin and Latrunculin A

I

Ibn Sina Hospital

Status

Completed

Conditions

Infertility

Treatments

Other: Doing ICSI I a medium supplemented with Ionomycin and Latrunculin A

Study type

Interventional

Funder types

Other

Identifiers

NCT03678610
Ibnsina-ICSI-ionomycin-LA

Details and patient eligibility

About

Using Latrunculin A and Ionomycin would improve the outcome of ICSI if the handling medium during the ICSI procedure has them.

Enrollment

700 patients

Sex

Female

Ages

18 to 42 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • indication for ICSI

Exclusion criteria

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

700 participants in 2 patient groups

ICSI medium supplemented with Ionomycin and Latrunculin A
Experimental group
Treatment:
Other: Doing ICSI I a medium supplemented with Ionomycin and Latrunculin A
ICSI medium as it is
No Intervention group

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems